Keeping faith in bisphosphonates: Pamidronate for CRPS

As Libby Parfitt reported back in January 2018, the multiple-centre trial of a seemingly promising drug for the treatment of CRPS, Zoledronic Acid (also known as Zoledronate), was halted by the pharmaceutical company, Axsome Therapeutics. The reason given for this move was “futility”; in other words, the data collected to that point suggested that the …

Keeping faith in bisphosphonates: Pamidronate for CRPS Read More »

Report of European Pain Federation task force on CRPS published

Jan 13th 2019 | article by Richard Lowes The standard of clinical practice for most conditions varies from country to country and this is certainly the case for Complex Regional Pain Syndrome (CRPS). Indeed, in Europe there has long been a desire to see a uniformity in approach to the diagnosis, treatment and management of …

Report of European Pain Federation task force on CRPS published Read More »

Vitamins and supplements for Chronic Pain

Feb 11th 2019 | article by Richard Lowes Quite rightly, the first port of call for most people suffering chronic pain in any of its many guises are mainstream treatments and medications. However, many sufferers, particularly those whose chronic pain condition has become well-established and possibly resistant to therapy, turn for some symptomatic relief to …

Vitamins and supplements for Chronic Pain Read More »

New non-addictive drug may be better painkiller than morphine

Feb 15th, 2019 | article by Richard Lowes We have considered in an earlier article how nanotechnology – science and engineering on an extremely small scale – may help to revolutionise medicine, including the way that drugs act within the body. We have considered in an earlier article how nanotechnology – science and engineering on …

New non-addictive drug may be better painkiller than morphine Read More »

UK war on opioids: new prescribing guidelines to be developed

Feb 28th 2019 | article by Libby Parfitt As chronic pain patients have feared, it looks like the war on opioid painkillers has reached the UK. There’s been a spate of reports in newspapers recently, highlighting the extent of opioid prescribing in the UK and the dangers associated with it. The Times published a lengthy …

UK war on opioids: new prescribing guidelines to be developed Read More »

Clinical trial on neridronate in Germany

Aachen. CRPS/Sudeck’s disease was conducted by the pharmaceutical manufacturer Grünenthal, Aachen, to conduct a clinical study on the active ingredient neridronate. Neridronic acid) launched an aminobisphosphate. In various clinics in Germany, sufferers can take part in this clinical trial. The studies will be conducted at sites in the US, Canada, Germany, France, the UK, Spain, …

Clinical trial on neridronate in Germany Read More »

Position paper on the treatment of CRPS in Europe/Standards

A position paper on the treatment of CRPS in Europe was published in the European Journal of Pain in January. Well-known medical practitioners from Great Britain, Germany, Switzerland, Belgium, the Netherlands, France, Denmark and Poland as well as from Irsael and Australia have together put together the current methods and best practices to raise standards …

Position paper on the treatment of CRPS in Europe/Standards Read More »